Novel pentapeptides, processes for their production, pharmaceuti

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2601125E, A61K 3700, C07C10352

Patent

active

044056079

ABSTRACT:
Pentapeptides of formula I, ##STR1## wherein Z.sup.1 =H, CH.sub.3 or amidino; R.sub.1 =H or alkyl and R.sub.2 =H or R.sub.1 +R.sub.2 =--CH.sub.2 --CH.sub.2 --; R.sub.3 =m- or p--OH or -alkoxy; B=residue of a (D)-.alpha.-amino acid; R.sub.4 =H or alkyl; Z.sup.2 =optionally substituted phenyl; and E=.beta.-amino alcohol residue (whereby when Z.sup.1 =H or CH.sub.3, R.sub.4 =C.sub.3-4 -alkyl) as well as their esters and the acid addition salts and complexes of such peptides and esters. Compounds according to the invention have valuable pharmacological, in particular LH-secretion inhibiting activity.

REFERENCES:
patent: 4254023 (1981-03-01), Stewart et al.
patent: 4261888 (1981-04-01), Bauer et al.
patent: 4283329 (1981-08-01), Gesellchen et al.
patent: 4322339 (1982-03-01), Gesellchen et al.
Biol. Abstr. 70, 66983.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel pentapeptides, processes for their production, pharmaceuti does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel pentapeptides, processes for their production, pharmaceuti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel pentapeptides, processes for their production, pharmaceuti will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-587778

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.